Agomelatine efficacy in treatment resistant obsessive-compulsive disorder: A randomized double-blind clinical trial.

This study, while not confirming significant efficacy, underscores the need for continued investigation into agomelatine's potential in treating specific subgroups of OCD patients, emphasizing the necessity for more comprehensive and well-controlled trials in the future.